Dual-Target CAR-NK Cells

· Beijing Biotech

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Dual-Target CAR-NK Cells, covering 2026-03-10 to 2026-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC) [Phase 1, Phase 2]